The global urinary bag market is poised to surpass US$ 1,899.3 million by 2023, surging at a remarkable CAGR of 4.4% through 2033 to reach US$ 2,911.7 million.
The urinary bag market has experienced significant growth in recent years due to the increasing prevalence of urinary incontinence and urinary retention disorders. With growing environmental concerns, there is a rising emphasis on developing sustainable urinary bag solutions. Furthermore, manufacturers are increasingly exploring eco-friendly materials, recycling initiatives, and waste reduction strategies to address these sustainability concerns.
What is the Impact of Consolidation Efforts on Urinary Bag Sales?
Acquisition by BD: On December 29, 2017, BD completed the acquisition of Bard, aiming to create a medical technology company that improves disease treatment and healthcare processes.
Hollister's Distribution Center: In 2018, Hollister Incorporated opened a new distribution center in the Netherlands, enhancing its distribution capabilities.
How Market Players are Gaining from Rising Cases of Chronic Ailments?
Urinary incontinence issues are very common in people over 40 years of age, according to a study released by the National Association for Continence in 2017. The condition leads to a low quality of life and an increased risk of morbidity. Various apps and marketing campaigns are being used by market players to raise awareness about urinary bags.
| Attributes | Details |
|---|---|
| Urinary Bag Market Size (2023) | US$ 1,899.3 million |
| Urinary Bag Market Projected Size (2033) | US$ 2,911.7 million |
| Urinary Bag Market Value-based CAGR (2023 to 2033) | 4.4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global urinary bag market expanded at a moderate CAGR of over 4.1% between 2018 and 2022. Continual growth in healthcare expenditure, particularly in developing economies, improves access to healthcare services and urinary management solutions. Increased investment in healthcare infrastructure is likely to drive the demand for urinary bags.
Ongoing advancements in urinary bag technology, including the incorporation of innovative features and materials, enhance product performance, patient comfort, and infection prevention. These advancements greatly contribute to increased adoption and market growth.
Leading companies are actively participating in partnerships, collaborations, and mergers and acquisitions to expand their product portfolio. Furthermore, the availability of advanced urinary bag products has also increased with the number of visits for cancer treatments in hospitals. Such factors are expected to create opportunities for the expansion of the urinary bag market over the forecast period, which is projected to expand at a CAGR of 4.4% from 2023 to 2033.
The market in the United States of America accounts for more than 90% of North America market, where the market for urinary bags in North America was predicted to amass revenue of 34.5% in 2022.
The healthcare system of the United States of America is well-known for its infrastructure and spending and the same can be attributed to the country’s value share of 31.8% in 2022.
Applications in cancer care centers and hospitals are influenced by regulations and insurance policies, which in turn accelerates the growth of the market in the country.
Government and regulatory authorities in the United States of America are implementing several cost-containment plans to ease the burden on the healthcare sector.
The United States of America government is actively taking initiatives to encourage various research activities for the development and treatment of urinary diseases. Telefex completed two large-scale acquisitions: NeoTract, Inc. (NeoTract) and Vascular Solutions, Inc. (Vascular Solutions).
Germany held a share of 9.5% in 2022 and is expected to advance at a steady pace in the coming years.
Germany is one of the world’s leading production hubs for pharmaceutical and healthcare products. Manufacturers in the country have created a competitive environment by developing products and leveraging cutting-edge research for functionality improvements.
The manufacturers are constantly investing in operation expansions that enable companies to optimize research and development, resulting in a promising product pipeline. Moreover, the prioritization of areas with high patient needs and working toward the development of innovative products is likely to generate substantial returns.
The United Kingdom market is expected to secure a 4.4% CAGR from 2023 to 2033. The United Kingdom’s healthcare system is largely funded by the government. It is considered one of the most successful healthcare systems in the world.
According to FMI’s analysis, the United Kingdom is identified as the leading market among the countries of Europe. Furthermore, rising research efforts, increasing pipeline drugs, and the presence of several key players create a huge opportunity for urinary bag producers in the country.
The market in China is projected to expand at a CAGR of 4.4% during the forecast period. China is the second-large pharmaceutical market in the world. It is significantly growing based on two main factors such as large-scale capital investment and rapid productivity growth. These two factors have projected the country as an appealing destination for foreign investments and large domestic savings.
The country has been transforming from being a low economy to a market-oriented country since the 1970s. With the growth in medical tourism, the sales prospects of urinary bags are likely to remain positive for the foreseeable future.
India accounts for more than 50% of the South Asia urinary bag industry. In recent years, pharmaceutical companies in India have hugely invested in research operations. The demand for urinary bags is likely to grow, with significant impetus from the ongoing covid-19 pandemic.
As per FMI, the market for urinary bags in India is poised to expand at a rate of 6.9% from 2023 to 2033. Public-private partnerships have become a leading business in India due to factors such as the presence of government-funded pharmaceutical and medical institutions with advanced facilities for clinical trials. Moreover, manufacturers in India are expanding their businesses by exporting their products to various other countries, which proves to be beneficial for India’s market.
Principal Consultant
Based on urinary bag products, drainage bags are leading the market and held a market share of over 52.24% in 2022.
Various surgical interventions, such as urological surgeries, abdominal surgeries, and pelvic surgeries, often require temporary or permanent urinary drainage. The increasing number of surgical procedures performed globally contributes to the demand for drainage bags.
There is a growing trend toward home healthcare and long-term care for individuals with chronic illnesses or disabilities. These settings often require urinary drainage bags for patients who prefer to receive care at home, further driving the demand for these products.
Based on capacity, 1000 ml capacity urine bags are preferred since it allows for easy movement of patients with sufficient quantity. This helps the patient to move freely without significant addition of weight. As a result, the demand for 1000 ml capacity urine bags held a 35.09% value share in 2022, according to FMI.
The larger capacity of 1000 ml capacity urine bags can help reduce the feeling of fullness and discomfort experienced by patients with high urine output. It allows for efficient urine collection, preventing overflow or leakage, and providing improved comfort throughout the day or night.
Disposable urinary bags accounted for more than 75.9% of the global market share in 2022. These products offer satisfaction to users with a low risk of infectious diseases.
Users also choose disposable urinary drainage bags owing to ease of use. In the case of reusable bags, careful cleaning and disinfection according to FDA guidelines are critical to prevent infection transfer from one patient to the next. Since the risk of infection transmission is low with disposable urinary drainage bags, healthcare professionals tend to prefer them over normal urinary bags, swaying the share of the sub-segment.
Adult urinary bags accounted for more than 92.1% of the global market share in 2022. Overactive bladders and urinary urgency are most common in people over 40 years of age, according to a study released by the National Association for Continence in 2017.
The adult segment is anticipated to grow significantly during the forecast period, reflecting notable growth than pediatric products.
Urinary bag consumption by hospitals amassed a revenue share of 40.2% in 2022 as hospitals are highly preferred for patient care for ulcerative colitis and inflammatory bowel disease (IBD), especially among geriatrics. These diseases are common in developed economies, with high penetration in urban areas.
The COVID-19 epidemic has increased hospital admission rates all over the world, which in turn has bolstered urinary bag requirements.
The urinary bag market is consolidated in nature, with the presence of leading players operating in this space. The focus is primarily on research & development activities mainly for urinary retention, urine incontinence, and urological or gynecological surgeries.
Market players are also engaged in the expansion of global and regional presence through acquisitions, expansions, product launches, and improvement of distribution channels.
Developments in the market:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Asia Pacific is projected to emerge as a lucrative market for urinary bags.
The growth potential of the urinary bag market is 4.4% through 2033.
The high cost of adoption is likely to limit market growth.
North America is likely to generate 15% revenue in 2023.
The market will generate revenue of US$ 2,911.7 million in 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Large Bags
5.3.2. Leg Bags
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Usage
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Usage, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Usage, 2023 to 2033
6.3.1. Reusable
6.3.2. Disposable
6.4. Y-o-Y Growth Trend Analysis By Usage, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Usage, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Capacity
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Capacity, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Capacity, 2023 to 2033
7.3.1. Upto 500 ml
7.3.2. 500-1000 ml
7.3.3. Above 1000 ml
7.4. Y-o-Y Growth Trend Analysis By Capacity, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Capacity, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
8.3.1. Hospitals and Clinics
8.3.2. Others
8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. MEA
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. USA
10.2.1.2. Canada
10.2.2. By Product
10.2.3. By Usage
10.2.4. By Capacity
10.2.5. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Usage
10.3.4. By Capacity
10.3.5. By End User
10.4. Key Takeaways
11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Product
11.2.3. By Usage
11.2.4. By Capacity
11.2.5. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Usage
11.3.4. By Capacity
11.3.5. By End User
11.4. Key Takeaways
12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. UK
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Europe
12.2.2. By Product
12.2.3. By Usage
12.2.4. By Capacity
12.2.5. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Usage
12.3.4. By Capacity
12.3.5. By End User
12.4. Key Takeaways
13. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.1.4. Singapore
13.2.1.5. Thailand
13.2.1.6. Indonesia
13.2.1.7. Australia
13.2.1.8. New Zealand
13.2.1.9. Rest of Asia Pacific
13.2.2. By Product
13.2.3. By Usage
13.2.4. By Capacity
13.2.5. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Usage
13.3.4. By Capacity
13.3.5. By End User
13.4. Key Takeaways
14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Product
14.2.3. By Usage
14.2.4. By Capacity
14.2.5. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Usage
14.3.4. By Capacity
14.3.5. By End User
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Product
15.1.2.2. By Usage
15.1.2.3. By Capacity
15.1.2.4. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Product
15.2.2.2. By Usage
15.2.2.3. By Capacity
15.2.2.4. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Product
15.3.2.2. By Usage
15.3.2.3. By Capacity
15.3.2.4. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Product
15.4.2.2. By Usage
15.4.2.3. By Capacity
15.4.2.4. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Product
15.5.2.2. By Usage
15.5.2.3. By Capacity
15.5.2.4. By End User
15.6. UK
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Product
15.6.2.2. By Usage
15.6.2.3. By Capacity
15.6.2.4. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Product
15.7.2.2. By Usage
15.7.2.3. By Capacity
15.7.2.4. By End User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Product
15.8.2.2. By Usage
15.8.2.3. By Capacity
15.8.2.4. By End User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Product
15.9.2.2. By Usage
15.9.2.3. By Capacity
15.9.2.4. By End User
15.10. China
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Product
15.10.2.2. By Usage
15.10.2.3. By Capacity
15.10.2.4. By End User
15.11. Japan
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Product
15.11.2.2. By Usage
15.11.2.3. By Capacity
15.11.2.4. By End User
15.12. South Korea
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Product
15.12.2.2. By Usage
15.12.2.3. By Capacity
15.12.2.4. By End User
15.13. Singapore
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Product
15.13.2.2. By Usage
15.13.2.3. By Capacity
15.13.2.4. By End User
15.14. Thailand
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Product
15.14.2.2. By Usage
15.14.2.3. By Capacity
15.14.2.4. By End User
15.15. Indonesia
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Product
15.15.2.2. By Usage
15.15.2.3. By Capacity
15.15.2.4. By End User
15.16. Australia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Product
15.16.2.2. By Usage
15.16.2.3. By Capacity
15.16.2.4. By End User
15.17. New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Product
15.17.2.2. By Usage
15.17.2.3. By Capacity
15.17.2.4. By End User
15.18. GCC Countries
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Product
15.18.2.2. By Usage
15.18.2.3. By Capacity
15.18.2.4. By End User
15.19. South Africa
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Product
15.19.2.2. By Usage
15.19.2.3. By Capacity
15.19.2.4. By End User
15.20. Israel
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Product
15.20.2.2. By Usage
15.20.2.3. By Capacity
15.20.2.4. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product
16.3.3. By Usage
16.3.4. By Capacity
16.3.5. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Medline Industries, Inc.
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Cardinal Health, Inc.
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Hollister Incorporated
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Teleflex Incorporated
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Cook Medical
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Moore Medical LLc
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Mckesson Medical-Surgical Inc.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Arcus Medical LLc
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Urocare
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Covidien
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. Coloplast A/S
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
17.1.12. B. Braun
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.12.5.2. Product Strategy
17.1.12.5.3. Channel Strategy
17.1.13. Romsons
17.1.13.1. Overview
17.1.13.2. Product Portfolio
17.1.13.3. Profitability by Market Segments
17.1.13.4. Sales Footprint
17.1.13.5. Strategy Overview
17.1.13.5.1. Marketing Strategy
17.1.13.5.2. Product Strategy
17.1.13.5.3. Channel Strategy
17.1.14. Poly Medicure Limited
17.1.14.1. Overview
17.1.14.2. Product Portfolio
17.1.14.3. Profitability by Market Segments
17.1.14.4. Sales Footprint
17.1.14.5. Strategy Overview
17.1.14.5.1. Marketing Strategy
17.1.14.5.2. Product Strategy
17.1.14.5.3. Channel Strategy
17.1.15. G.Surgiwear Ltd
17.1.15.1. Overview
17.1.15.2. Product Portfolio
17.1.15.3. Profitability by Market Segments
17.1.15.4. Sales Footprint
17.1.15.5. Strategy Overview
17.1.15.5.1. Marketing Strategy
17.1.15.5.2. Product Strategy
17.1.15.5.3. Channel Strategy
17.1.16. Kiefel Medical
17.1.16.1. Overview
17.1.16.2. Product Portfolio
17.1.16.3. Profitability by Market Segments
17.1.16.4. Sales Footprint
17.1.16.5. Strategy Overview
17.1.16.5.1. Marketing Strategy
17.1.16.5.2. Product Strategy
17.1.16.5.3. Channel Strategy
17.1.17. Jolfamar
17.1.17.1. Overview
17.1.17.2. Product Portfolio
17.1.17.3. Profitability by Market Segments
17.1.17.4. Sales Footprint
17.1.17.5. Strategy Overview
17.1.17.5.1. Marketing Strategy
17.1.17.5.2. Product Strategy
17.1.17.5.3. Channel Strategy
17.1.18. UROMED
17.1.18.1. Overview
17.1.18.2. Product Portfolio
17.1.18.3. Profitability by Market Segments
17.1.18.4. Sales Footprint
17.1.18.5. Strategy Overview
17.1.18.5.1. Marketing Strategy
17.1.18.5.2. Product Strategy
17.1.18.5.3. Channel Strategy
17.1.19. Wujiang Evergreen Ex/Im Co. Ltd
17.1.19.1. Overview
17.1.19.2. Product Portfolio
17.1.19.3. Profitability by Market Segments
17.1.19.4. Sales Footprint
17.1.19.5. Strategy Overview
17.1.19.5.1. Marketing Strategy
17.1.19.5.2. Product Strategy
17.1.19.5.3. Channel Strategy
17.1.20. Leboo Healthcare Products Limited
17.1.20.1. Overview
17.1.20.2. Product Portfolio
17.1.20.3. Profitability by Market Segments
17.1.20.4. Sales Footprint
17.1.20.5. Strategy Overview
17.1.20.5.1. Marketing Strategy
17.1.20.5.2. Product Strategy
17.1.20.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports
Urinary Bag Market
